Royal Bank of Canada
EVH icon

Royal Bank of Canada’s Evolent Health EVH Stock Holding History

Royal Bank of Canada’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57K Buy
25,161
+8,563
+52% +$27.2K ﹤0.01% 5426
2025
Q4 		$65K Sell
16,598
-137,368
-89% -$764K ﹤0.01% 5410
2025
Q3 		$1.3M Buy
153,966
+133,043
+636% +$1.29M ﹤0.01% 3758
2025
Q2 		$235K Buy
20,923
+4,337
+26% +$39.8K ﹤0.01% 5039
2025
Q1 		$156K Sell
16,586
-18,622
-53% -$188K ﹤0.01% 4886
2024
Q4 		$397K Sell
35,208
-29,395
-46% -$517K ﹤0.01% 4252
2024
Q3 		$1.83M Buy
64,603
+36,811
+132% +$949K ﹤0.01% 3057
2024
Q2 		$531K Sell
27,792
-12,042
-30% -$308K ﹤0.01% 3972
2024
Q1 		$1.31M Sell
39,834
-9,770
-20% -$312K ﹤0.01% 3238
2023
Q4 		$1.64M Buy
49,604
+21,807
+78% +$617K ﹤0.01% 3229
2023
Q3 		$757K Sell
27,797
-70,457
-72% -$1.96M ﹤0.01% 3683
2023
Q2 		$2.98M Sell
98,254
-38,626
-28% -$1.25M ﹤0.01% 2513
2023
Q1 		$4.44M Sell
136,880
-19,530
-12% -$618K ﹤0.01% 2166
2022
Q4 		$4.39M Sell
156,410
-2,350
-1% -$67.4K ﹤0.01% 2246
2022
Q3 		$5.71M Buy
158,760
+92,805
+141% +$3.27M ﹤0.01% 1974
2022
Q2 		$2.02M Buy
65,955
+5,289
+9% +$154K ﹤0.01% 2889
2022
Q1 		$1.96M Sell
60,666
-1,025
-2% -$26.8K ﹤0.01% 3073
2021
Q4 		$1.71M Buy
61,691
+41,652
+208% +$1.19M ﹤0.01% 3300
2021
Q3 		$621K Buy
20,039
+2,134
+12% +$51.2K ﹤0.01% 4169
2021
Q2 		$378K Buy
17,905
+2,051
+13% +$41.1K ﹤0.01% 4511
2021
Q1 		$320K Buy
15,854
+6,689
+73% +$127K ﹤0.01% 4559
2020
Q4 		$147K Sell
9,165
-1,955
-18% -$25.8K ﹤0.01% 5083
2020
Q3 		$138K Sell
11,120
-24,734
-69% -$291K ﹤0.01% 4783
2020
Q2 		$256K Sell
35,854
-66,799
-65% -$447K ﹤0.01% 4273
2020
Q1 		$558K Buy
102,653
+23,366
+29% +$209K ﹤0.01% 3514
2019
Q4 		$716K Buy
79,287
+1,539
+2% +$12.5K ﹤0.01% 3714
2019
Q3 		$560K Buy
77,748
+12,451
+19% +$89.3K ﹤0.01% 3769
2019
Q2 		$519K Buy
65,297
+4,590
+8% +$54.3K ﹤0.01% 3836
2019
Q1 		$763K Sell
60,707
-329,466
-84% -$5.22M ﹤0.01% 3414
2018
Q4 		$7.78M Buy
390,173
+339,997
+678% +$7.87M ﹤0.01% 1672
2018
Q3 		$1.42M Buy
50,176
+39,262
+360% +$937K ﹤0.01% 3098
2018
Q2 		$230K Buy
10,914
+1,350
+14% +$25.6K ﹤0.01% 4330
2018
Q1 		$137K Buy
9,564
+765
+9% +$10.9K ﹤0.01% 4518
2017
Q4 		$108K Sell
8,799
-4,943
-36% -$69.7K ﹤0.01% 4767
2017
Q3 		$245K Buy
13,742
+5,449
+66% +$112K ﹤0.01% 4365
2017
Q2 		$210K Buy
8,293
+7,654
+1,198% +$184K ﹤0.01% 4337
2017
Q1 		$14K Sell
639
-132
-17% -$2.53K ﹤0.01% 5802
2016
Q4 		$11K Buy
+771
New +$15.2K ﹤0.01% 6047
2016
Q1 		– Sell
-123
Closed -$1K – 6436
2015
Q4 		$1K Sell
123
-377
-75% -$5.55K ﹤0.01% 6464
2015
Q3 		$8K Buy
+500
New +$9.75K ﹤0.01% 5981

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's EVH Position: Q1 2026 in Review

Royal Bank of Canada increased its Evolent Health (EVH) stake by 52% in Q1 2026, buying an estimated $27.2K and bringing the position to 25,161 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #5426.

Royal Bank of Canada first reported a position in EVH in Q3 2015 and has held it in 40 quarters since. The position peaked at $7.78M in Q4 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Royal Bank of Canada held 25,161 shares of Evolent Health worth $57K as of Q1 2026.
  • Royal Bank of Canada bought 8,563 Evolent Health shares in Q1 2026, an estimated $27.2K.
  • Evolent Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5426 holding.
  • Royal Bank of Canada first reported a position in Evolent Health in Q3 2015 and has held it in 40 quarters since.
  • Royal Bank of Canada's Evolent Health position peaked at $7.78M in Q4 2018.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.